Lancet IDInfectious Disease
[Newsdesk] Brazil launches implementation study of lenacapavir
Summary
The ImPrEP LEN Brasil study, investigating lenacapavir for pre-exposure prophylaxis of HIV in young adults across seven Brazilian cities, was launched in January, 2026. Tony Kirby reports.
The ImPrEP LEN Brasil study, investigating lenacapavir for pre-exposure prophylaxis of HIV in young adults across seven Brazilian cities, was launched in January, 2026. Tony Kirby reports.